Abstract:

One of the most important causes of morbidity and mortality in obesity surgery is the events of deep venous thrombosis (DVT) and venous thrombembolism (VTE) that cover lung embolism (PE). This study aims to evaluate the results of VTE in patients performed by bariatric surgery and standard dose prevention. Patients and Method: Patients who were operated with a cause of morbid obesity between 2015-2019 were examined retrospectively. The study included the phenomena of laparoscopic sleeve gastrectomy and standard dose Enoksaparin prevention. Demographic data of patients, preoperative preparation and postoperative antiembolic treatment conditions were recorded. Results: 87 patients with laparoscopic sleeve gastrectomy were taken to study. 66 of the patients (75.8%) were female 21 (24.1%) men. The average age was 38.7 (18-55) The average stay in the hospital is 6.6 (3-69) days. Four patients (4,5%) developed postoperative complications. In two patients, the PE, mediastinitis and cutting sputum related to the leakage occurred in one case. The result: Despite the existing methods of prevention, VTE remains a major cause of morbidity and mortality in patients with obesity surgery. High-dose low molecular weight heparin (DMAH) use can cause bleeding, while low-dose DMAH use increases the likelihood of VTE. This is a limitation of the DMAH. New studies are needed for the application of the standard dose in the early period and after expulsion increased dosage.